Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance
详细信息 查看全文
- 作者：Qianqian Pang (1)
Jiaxin Ge (1)
Yongfu Shao (1)
Weiliang Sun (2)
Haojun Song (1)
Tian Xia (1)
Bingxiu Xiao (1)
Junming Guo (1) - 关键词：LINC00152 ; Long non ; coding RNA ; Long intergenic non ; coding RNA ; Gastric cancer ; Biomarker ; Gastric juice
- 刊名：Tumor Biology
- 出版年：2014
- 出版时间：June 2014
- 年：2014
- 卷：35
- 期：6
- 页码：5441-5447
- 全文大小：
- 参考文献：1. Huang L, Xu A, Li T, Han W, Wu S, Wang Y. Detection of perioperative cancer antigen 72-4 in gastric juice pre- and post-distal gastrectomy and its significances. Med Oncol. 2013;30:651. CrossRef
2. Zhang ZY, Ge HY. Micrometastasis in gastric cancer. Cancer Lett. 2013;336:34-5. CrossRef
3. Sana J, Faltejskova P, Svoboda M, Slaby O. Novel classes of non-coding RNAs and cancer. J Transl Med. 2012;10:103. CrossRef
4. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861-4. CrossRef
5. Ponting CP, Oliver PL, Reik W. Evolution and functions of long non-coding RNAs. Cell. 2009;136:629-1. CrossRef
6. Tang JY, Lee JC, Chang YT, Hou MF, Huang HW, Liaw CC, et al. Long noncoding RNAs-related diseases, cancers, and drugs. Sci World J. 2013;2013:943539.
7. Bánfai B, Jia H, Khatun J, Wood E, Risk B, Gundling Jr WE, et al. Long non-coding RNAs are rarely translated in two human cell lines. Genome Res. 2012;22:1646-7. CrossRef
8. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013;41:4976-7. CrossRef
9. Krishnan J, Mishra RK. Emerging trends of long non-coding RNAs in gene activation. FEBS J. 2014;281:34-5. CrossRef
10. Singh DK, Prasanth KV. Functional insights into the role of nuclear-retained long noncoding RNAs in gene expression control in mammalian cells. Chromosome Res. 2013;21:695-11. CrossRef
11. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol. 2010;220:126-9. CrossRef
12. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29:1810-. CrossRef
13. Luo M, Li ZW, Wang W, Zeng YG, Liu ZH, Qiu JX. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013;333:213-1. CrossRef
14. Song H, Sun W, Ye G, Ding X, Liu Z, Zhang S, et al. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med. 2013;11:225. CrossRef
15. Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H, et al. Gastric juice microRNAs as potential biomarkers for the screening of gastric cancer. Cancer. 2013;119:1618-6. CrossRef
16. Riedmaier I, Pfaffl MW. Transcriptional biomarkers—high throughput screening, quantitative verification, and bioinformatical validation methods. Methods. 2013;59:3-. CrossRef
17. Borel F, Konstantinova P, Jansen PL. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J Hepatol. 2012;56:1371-3. CrossRef
18. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354-1. CrossRef
19. Kam Y, Rubinstein A, Naik S, Djavsarov I, Halle D, Ariel I, et al. Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT-PNA molecular beacons. Cancer Lett. 2013. doi:10.1016/j.canlet.2013.02.014 .
20. Mei D, Song H, Wang K, Lou Y, Sun W, Liu Z, et al. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med Oncol. 2013;30:709. CrossRef
21. Sun W, Wu Y, Yu X, Liu Y, Song H, Xia T, et al. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Tumour Biol. 2013;34:2697-01. CrossRef
22. Pickard MR, Maarabouni MM, Williams GT. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta. 1832;2013:1613-3.
23. Yang C, Li X, Wang Y, Zhao L, Chen W. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene. 2012;496:8-6. CrossRef
24. Yang F, Xue XC, Bi JW, Zheng LM, Zhi KK, Gu Y, et al. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol. 2013;139:437-5. CrossRef
25. Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, et al. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene. 2012;31:4421-3. CrossRef
26. Cao WJ, Wu HL, He BS, Zhang YS, Zhang ZY. Analysis of long non-coding RNA expression profiles in gastric cancer. World J Gastroenterol. 2013;19:3658-4. CrossRef
27. Lipovich L, Johnson R, Lin CY. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim Biophys Acta. 2010;1799:597-15. CrossRef
28. Qiu MT, Hu JW, Yin R, Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumor Biol. 2013;34:613-0. CrossRef
29. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703-9. CrossRef
30. Tani H, Torimura M. Identification of short-lived long non-coding RNAs as surrogate indicators for chemical stress response. Biochem Biophys Res Commun. 2013;439:547-1. CrossRef - 作者单位：Qianqian Pang (1)
Jiaxin Ge (1)
Yongfu Shao (1)
Weiliang Sun (2)
Haojun Song (1)
Tian Xia (1)
Bingxiu Xiao (1)
Junming Guo (1)
1. Department of Biochemistry and Molecular Biology, Zhejiang Provincial Key Laboratory of Pathophysiology, Ningbo University School of Medicine, 818 Fenghua Road, Ningbo, 315211, China
2. Ningbo Yinzhou People’s Hospital and the Affiliated Hospital, Ningbo University School of Medicine, Ningbo, 315040, China - ISSN：1423-0380
文摘
It has been known that differential expression of long non-coding RNA (lncRNA) plays critical roles in carcinogenesis. However, the significance of lncRNA, especially long intergenic ncRNA (lincRNA, the main type of lncRNA family), in the diagnosis of gastric cancer is largely unknown. The aim of this study was to determine the expression level of LINC00152, a newfound lincRNA, in gastric carcinoma and its clinical association. The expression of LINC00152 in 71 pairs of tumorous and adjacent normal tissues from patients with gastric cancer was detected by quantitative real-time reverse transcription-polymerase chain reaction. And then, the potential associations between its level in gastric cancer tissue and the clinicopathological features were analyzed. Finally, a receiver operating characteristic (ROC) curve was constructed for differentiating patients with gastric cancer from patients with benign gastric diseases. The results showed that the expression level of LINC00152 in gastric carcinoma was significantly increased, compared with matched normal tissue (P--.045) and normal mucosa from health control (P--.004), respectively. Levels of LINC00152 in gastric cancer cell lines, BGC-823, MGC-803, and SGC-7901, were significantly higher than those in human normal gastric epithelial cell line GES-1. In addition, high expression of LINC00152 was correlated with invasion (P--.042). LINC00152 levels in gastric juice from patients with gastric cancer were further found significantly higher than those from normal controls (P--.002). Moreover, the area under the ROC curve (AUC) was up to 0.645 (95?% CI--.559-.740, P--.003). This study highlights that lincRNA LINC00152 might be a novel biomarker for predicting gastric cancer.